- | Country :
- Netherlands
- | organs : -
- | Specialty : -
Extract
This is a first-in-humans study of SRA-444. This study will provide an initial assessment of the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of SRA-444 (SR formulation) after administration of ascending single oral doses to healthy adult subjects.
Inclusion criteria
- Alzheimer Disease